• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Illumina

NASDAQ:ILMN

$43.84 $0.38 (0.87%)

REAL-TIME: Last trade at

4 Crucial Ingredients for the Perfect Investor

Review Of Analyst Upgrades This Week - Part V

Where Have the Big Ideas Gone?

Affymetrix Inks Distribution Pact - Analyst Blog

These 2 Stocks Were Left Bleeding

Hostile Takeover? More Like Nice Guy Showdown.

GlaxoSmithKline to Get Hostile with Offer for Human Genome

Affymetrix Beats Ests., Posts Loss - Analyst Blog

Top Analyst Upgrades & Downgrades (BNNY, CAB, CCL, CTRN, DPS, FSLR, ILMN, LEAP, NWL, PEP, PG, TWX, W

24/7 Wall St. Closing Bell (FSLR, PEP, PG, ILMN, CCL, ANV, AWR, BBEP, CDE, DISH, LPX, TSN, HFC, CHTR

Roche Pursuing Other Opportunities After Failed Illumina Bid - CEO

Genomic Health Beats Estimates - Analyst Blog

9 Weeks to Better Options Trading: Special Situations: Earnings Reports, Takeovers, and Extreme Mark

Pharma M&A Surge Spurred By Necessity And Opportunity

Buy, Sell, or Hold: Sequenom

Top Analyst Upgrades & Downgrades (ALSN, AZO, BIG, CHKP, CMG, CTRN, DWRE, GE, ILMN, LNKD, PBY, RMBS,

Stocks to watch Tuesday: Big Lots, Netflix, TI

Illumina Beats in 1Q - Analyst Blog

Illumina Beats on Both Top and Bottom Lines

Roche To Return Tendered Illumina Shares To Shareholders

Stocks: Earnings, economy and Europe back in focus

This Takeover Is Off the Table. Maybe.

Top Earnings Previews For Early In The Week Ahead (COP, ILMN, NFLX, TXN, AMGN, AAPL, T, BIDU, COH, J

What’s Important in the Financial World (4/19/2012) Facebook $104 Billion Value, Gas Price Drop

Human Genome Sciences rejects takeover bid

Europe stocks rise ahead of auctions; Spain off

Roche Walks Away From Illumina

This Takover Is Off the Table. Maybe.

This Just In: More Upgrades and Downgrades

Hostile takeovers are back

Roche Stays Firm on Illumina Offer - Analyst Blog

Roche not to extend tender offer for Illumina

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

3rd UPDATE: Roche Says It Won't Extend Illumina Takeover Bid

DEALWATCH: Battle May Be Over, But War For Illumina Could Resume

Media Digest (4/13/2012) Reuters, WSJ, NYT, FT, Bloomberg

Roche's 1Q Sales Climb Up - Analyst Blog

It's Time to Start Buying Into the Next Bubble

Roche Sees No Reason To Raise Illumina Offer

You, Sir, Are No Apple (but We Still Want to Buy You)

See More Articles...